RSV Vaccines - Pediatric/Maternal

Cost effectiveness analysis for nirsevimab – CDC model; Cost effectiveness analysis for nirsevimab – Comparison to manufacturer
model; Evidence to Recommendations framework for nirsevimab; Clinical considerations for nirsevimab; Safety and Efficacy of RSV Bivalent PreF Maternal Vaccine; Workgroup considerations

This video can also be viewed at
https://www.cdc.gov/vaccines/videos/low-res/ACIPFeb2023/ACIP-6_RSV_Vaccines-Pediatric-Maternal_02-23-2023_LowRes.mp4